Close
American Drug Delivery & Formulation Summit
Xylem

News

DFE Pharma demonstrates Impact of Powder Properties on the Rheological Behavior of Excipients

DFE Pharma, a global leader in pharmaceutical excipient solutions, is continuously supporting relevant scientific research and innovations in its field. With the recent publication of a new study demonstrating the impact of powder properties on the rheological behavior of excipients,...

Heraeus completes multi-million Euro cancer therapy API capacity expansion

Heraeus Pharmaceutical Ingredientsโ€™ additional production line for Platinum-based highly potent active pharmaceutical ingredients (Pt hAPIs) is now fully operational at the companyโ€™s headquarters in Hanau, Germany. Heraeus, a business line of Heraeus Precious Metals, is the leading global market supplier...

KYOWA Pharmaceutical Industry Co. Ltd. Partners with Bora Pharmaceuticals to manufacture generic product for filing in Japan

KYOWA Pharmaceutical Industry Co. Ltd., a premier Japanese pharmaceutical company, has contracted with Bora Pharmaceutical Laboratories Inc. (Zhunan), a division of Bora Pharmaceuticals for the manufacturing of a generic product for filing in Japan. KYOWA will be the first...

Metrics Contract Services Appoints Senior Director of Scientific and Technical Affairs

Metrics Contract Services, the contract pharmaceutical development and manufacturing division of Mayne Pharma, welcomes Anshul Gupte, PhD as Senior Director, Scientific and Technical Affairs. In that capacity, Anshul will be responsible for technical and scientific oversight of client projects. He...

Stelis Biopharma appoints Mark W. Womack as the new CEO

Stelis Biopharma Limited (Stelis or Company), a vertically integrated biopharma and vaccines Company and the biotech arm of Strides Pharma Science Limited, announced the appointment of Mark W. Womackย (Mark)ย as the new Chief Executive Officer (CEO). Mark is also the Managing...

Virus Safety in Continuous Processes

Virus safety is a key element in biopharmaceutical manufacturing. Inherently, animal cell culture involves risks related to virus safety. Chinese Hamster Ovary (CHO) cell lines are the most common production platform for expressing glycosylated proteins and monoclonal antibodies. Being...

Valneva Announces Positive Phase 3 Pivotal Results for its Single-Shot Chikungunya Vaccine Candidate

Valneva SE, a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need, announced positive topline results from the Phase 3 pivotal trial of its single-shot chikungunya vaccine candidate,...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป